Hemostats Market Size, Growth, Industry Share, Emerging Trends and Future Outlook 2024-2031

Comments · 11 Views

The Hemostats Market was valued at $2.6 Bn in 2022 and is expected to reach $4.11 Bn by 2030 and grow at a CAGR of 5.9% during the forecast period of 2023-2030.

The global hemostats market, valued at $2.6 billion in 2022, is projected to achieve significant growth, reaching $4.11 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030.

Key Players

The major players are C.R Bard, Baxter, Teleflex Incorporated, Ethicon, Medtronic Plc, Pfizer, B Braun Melsungen AG, and others.

Market Analysis

The hemostats market is witnessing robust growth driven by an increase in surgical procedures, rising trauma cases, and advancements in surgical technologies. The growing geriatric population and the prevalence of conditions requiring surgical intervention, such as cardiovascular diseases and cancer, are significant factors contributing to the market's expansion.

Key segments in the market include thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Among these, thrombin-based hemostats hold a dominant market share due to their efficacy and ease of use.

Key Market Segmentation:

By Type

  • Thrombin- based hemostats

  • Gelatin-Based hemostats

  • Collagen-Based hemostats

  • Combination hemostats

  • Other

By Formulation

  • Matrix Gel Hemostats

  • Sheet Pad hemostats

  • Powder Hemostats

  • Sponge Hemostats

By Application

  • Orthopedic Surgery

  • General surgery

  • Neurological surgery

  • Cardiovascular Surgery

  • Others

Impact of the Russia-Ukraine Conflict

The ongoing Russia-Ukraine conflict has had notable repercussions on the global hemostats market. Supply chain disruptions, increased costs of raw materials, and challenges in logistics have affected the production and distribution of hemostatic products. Companies operating in the region have faced operational hurdles, impacting market growth. However, the market has shown resilience, with key players adapting to new supply chain strategies and exploring alternative sources for raw materials.

Impact of Economic Slowdown

The global economic slowdown has also influenced the hemostats market. Budget constraints in healthcare systems, particularly in developing economies, have led to a cautious approach towards expenditure on advanced surgical products. Despite these challenges, the essential nature of hemostatic agents in surgical procedures ensures a steady demand, with gradual recovery anticipated as economic conditions improve.

Regional Analysis

North America holds the largest share of the hemostats market, driven by a well-established healthcare infrastructure, high surgical volumes, and strong presence of key market players. Europe follows closely, with significant contributions from countries like Germany, France, and the UK.

The Asia-Pacific region is poised for the fastest growth during the forecast period. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about advanced surgical products contribute to this trend. Notably, China and India are emerging as key markets due to their large patient populations and increasing number of surgical procedures.

Key Takeaways

  • The global hemostats market is projected to grow from $2.6 billion in 2022 to $4.11 billion by 2030, at a CAGR of 5.9%.
  • Growth is driven by increased surgical procedures, advancements in surgical technologies, and rising trauma cases.
  • The Russia-Ukraine conflict has caused supply chain disruptions, impacting production and distribution.
  • The global economic slowdown has led to cautious healthcare spending, particularly in developing regions.
  • North America and Europe are key markets, with Asia-Pacific anticipated to experience the fastest growth.
  • Companies are adapting to new supply chain strategies and exploring alternative sources to mitigate challenges.

Other Trending Report

Medical X-ray Market Share

Sleep Disorder Treatment Market Share

Tuberculosis (TB) Diagnostics Market Share

Blood Group Typing Market Share

Chlamydia Infection Treatment Market Share

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development Strategy


Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com   

Read more